METHOTREXATE (MTX) AND ASPARAGINASE (ASP) IN DRUG-REFRACTORY HUMAN TUMORS

被引：0
|
作者：
RENTSCHLER, R [1 ]
LIVINGSTON, R [1 ]
MOUNTAIN, C [1 ]
机构：
[1] MD ANDERSON HOSP & TUMOR INST,HOUSTON,TX 77025
来源：
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH | 1976年 / 17卷 / MAR期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：152 / 152
页数：1
相关论文
共 50 条
  • [1] SEQUENTIAL L-ASPARAGINASE (ASP) AND HIGH DOSE METHOTREXATE (MTX) IN REFRACTORY STAGE-IV BREAST-CANCER
    YAP, HY
    BENJAMIN, RS
    BLUMENSCHEIN, G
    TASHIMA, CK
    HORTOBAGYI, G
    BUZDAR, A
    BODEY, GP
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1978, 19 (MAR): : 412 - 412
  • [2] SEQUENTIAL COMBINATION OF METHOTREXATE (MTX) AND ASPARAGINASE (ASP) IN ADVANCED ACUTE NONLYMPHOCYTIC LEUKEMIA (ANLL)
    AMADORI, S
    TRIBALTO, M
    PASTORE, S
    CONCETTAPETTI, M
    MANDELLI, F
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1980, 21 (MAR): : 131 - 131
  • [3] TREATMENT OF REFRACTORY ADULT ACUTE-LEUKEMIA WITH SEQUENTIAL L-ASPARAGINASE (L-ASP) AND HIGH DOSE METHOTREXATE (MTX)
    YAP, BS
    BENJAMIN, RS
    MCCREDIE, KB
    BODEY, GP
    FREIREICH, EJ
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1978, 19 (MAR): : 359 - 359
  • [4] METHOTREXATE (MTX) AND ASPARAGINASE (AASE) COMBINATION CHEMOTHERAPY IN REFRACTORY ACUTE LYMPHOBLASTIC LEUKEMIA OF CHILDHOOD
    LOBEL, J
    OBRIEN, R
    ASPNES, G
    CAPIZZI, R
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1978, 19 (MAR): : 383 - 383
  • [5] METHOTREXATE (MTX) FOLLOWED IN 24 HOURS BY ASPARAGINASE (ASP) IN CHILDHOOD ADVANCED ACUTE NONLYMPHOCYTIC LEUKEMIA (ANLL)
    DAHL, G
    AMADORI, S
    MASON, C
    SIMONE, J
    AUR, RJA
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1978, 19 (MAR): : 84 - 84
  • [6] L-ASPARAGINASE (L-ASP) ANTAGONISM OF METHOTREXATE (MTX) CYTO-TOXICITY - AN ALTERNATIVE EXPLANATION
    JOLIVET, J
    COLE, D
    HOLCENBERG, JS
    POPLACK, DG
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1984, 25 (MAR): : 309 - 309
  • [7] Proteasome inhibitor PS-341 sensitizes drug-refractory human transitional cell tumors to gemcitabine
    Kamat, AM
    Karashima, T
    Davis, D
    Dinney, C
    McConkey, DJ
    JOURNAL OF UROLOGY, 2003, 169 (04): : 128 - 128
  • [8] Treatment of drug-refractory schizophrenia
    Fein, S
    PSYCHIATRIC ANNALS, 1998, 28 (04) : 215 - 219
  • [9] METHOTREXATE (MTX) AND MTX-METABOLITES IN TUMORS AND HOST TISSUES
    HOSOYA, R
    SASAKI, K
    WANG, YM
    SUTOW, WW
    SULLIVAN, MP
    JAFFE, N
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1980, 21 (MAR): : 330 - 330
  • [10] METHOTREXATE (MTX) VS METHOTREXATE-L-ASPARAGINASE (MTX AASE IN NON SMALL CELL LUNG-CANCER (NSCLC)
    NEIJSTROM, E
    RUDNICK, S
    DELANEY, D
    CAPIZZI, R
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1981, 22 (MAR): : 497 - 497
12345